Lupin Adjusts Evaluation Amid Mixed Technical Indicators and Strong Financial Performance
Lupin, a key player in the Pharmaceuticals & Drugs sector, has recently experienced a change in evaluation, reflecting shifts in market sentiment. Despite this, the company maintains a strong financial position, highlighted by a low Debt to Equity ratio and consistent positive operating profit growth, alongside impressive returns over the past year.
Lupin, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting shifts in its technical indicators. The stock's technical trend has transitioned, indicating a change in market sentiment. Key metrics such as the Moving Average Convergence Divergence (MACD) and the KST have shown a mildly bearish stance, while the Bollinger Bands present a mixed outlook, with weekly indicators leaning bearish and monthly indicators showing bullish tendencies.Despite this adjustment, Lupin has demonstrated a solid financial foundation. The company boasts a low Debt to Equity ratio of 0.10 times, indicating prudent financial management. Additionally, it has reported positive operating profit growth at an annual rate of 16.86%, alongside a remarkable return on capital employed (ROCE) of 18.68%. The stock has also consistently delivered positive results over the last nine quarters, with net sales reaching Rs 5,767.71 crore.
Lupin's performance over the past year has been noteworthy, generating a return of 27.47%, significantly outpacing broader market indices. The company's attractive valuation, characterized by a Price to Book Value ratio of 6, further underscores its competitive position within the industry.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
